Teleflex EBITDA Margin 2010-2022 | TFX

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Teleflex (TFX) over the last 10 years. The current EBITDA margin for Teleflex as of June 30, 2022 is .
Teleflex EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2022-06-30 $2.81B $0.78B 27.77%
2022-03-31 $2.82B $0.78B 27.58%
2021-12-31 $2.81B $0.78B 27.73%
2021-09-30 $2.76B $0.72B 26.03%
2021-06-30 $2.69B $0.70B 25.99%
2021-03-31 $2.54B $0.61B 23.82%
2020-12-31 $2.54B $0.66B 25.82%
2020-09-30 $2.51B $0.68B 27.00%
2020-06-30 $2.53B $0.66B 26.04%
2020-03-31 $2.61B $0.72B 27.67%
2019-12-31 $2.60B $0.64B 24.61%
2019-09-30 $2.56B $0.64B 24.91%
2019-06-30 $2.52B $0.60B 23.86%
2019-03-31 $2.48B $0.53B 21.24%
2018-12-31 $2.45B $0.54B 21.93%
2018-09-30 $2.40B $0.50B 20.98%
2018-06-30 $2.33B $0.52B 22.22%
2018-03-31 $2.25B $0.58B 25.73%
2017-12-31 $2.15B $0.53B 24.78%
2017-09-30 $2.07B $0.49B 23.72%
2017-06-30 $1.99B $0.46B 23.15%
2017-03-31 $1.93B $0.44B 22.93%
2016-12-31 $1.87B $0.45B 23.97%
2016-09-30 $1.84B $0.48B 26.03%
2016-06-30 $1.83B $0.47B 25.66%
2016-03-31 $1.81B $0.45B 24.70%
2015-12-31 $1.81B $0.44B 24.36%
2015-09-30 $1.80B $0.41B 22.82%
2015-06-30 $1.81B $0.42B 22.99%
2015-03-31 $1.83B $0.42B 22.73%
2014-12-31 $1.84B $0.41B 22.34%
2014-09-30 $1.82B $0.39B 21.71%
2014-06-30 $1.77B $0.37B 21.05%
2014-03-31 $1.72B $0.36B 20.59%
2013-12-31 $1.70B $0.34B 20.09%
2013-09-30 $1.67B $0.34B 20.54%
2013-06-30 $1.62B $0.32B 19.95%
2013-03-31 $1.58B $0.32B 20.29%
2012-12-31 $1.55B $0.33B 21.21%
2012-09-30 $1.53B $0.33B 21.74%
2012-06-30 $1.52B $0.34B 22.60%
2012-03-31 $1.52B $0.34B 22.17%
2011-12-31 $1.49B $0.33B 21.90%
2011-09-30 $1.43B $0.31B 21.54%
2011-06-30 $1.41B $0.30B 21.18%
2011-03-31 $1.38B $0.30B 21.97%
2010-12-31 $1.40B $0.32B 22.91%
2010-09-30 $1.19B $0.33B 27.43%
2010-06-30 $1.28B $0.34B 26.70%
2010-03-31 $1.36B $0.35B 25.48%
2009-12-31 $1.44B $0.35B 24.11%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.732B $2.810B
Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.040B 20.78
Edwards Lifesciences (EW) United States $52.534B 37.17
Alcon (ALC) Switzerland $29.415B 24.91
STERIS (STE) Ireland $16.731B 20.78
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Glaukos (GKOS) United States $2.385B 0.00
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.035B 15.85
Artivion (AORT) United States $0.537B 51.19